bevacizumab
roche
['beva', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'bevacizumab', 'crcsm']
folfoxiri plus bevacizumab improves pfs, orr at expense of increased toxicity in crc liver metastases #asco22 #crcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.